|
Dr. Stephen Ferguson is a study director for CellzDirect with expertise in the areas of receptor-mediated CYP450 gene regulation and the use of human hepatocyte model systems to study drug metabolism and induction. Dr. Ferguson serves as a study director for various projects including induction, reaction phenotyping, inhibition, metabolic stability, and research & development projects. Formerly, Dr. Ferguson was a research fellow in the Human Metabolism Section of the Laboratory of Pharmacology and Chemistry at the National Institute on Environmental Health Sciences. As a research postdoctoral fellow in Dr. Joyce Goldstein’s laboratory, Dr. Ferguson studied the mechanisms of drug induction and pharmacogenetics in collaboration with Dr. Masahiko Negishi and Dr. Edward LeCluyse. Dr. Ferguson received his Ph.D. in chemistry in 2000 in the North Carolina State University laboratory of Dr. Charles Cornman, where he utilized molecular biology tools to study and develop novel metalloproteins with transition metals for future development strategies of catalytic metalloantibodies. Dr. Ferguson has published 10 peer-reviewed articles in the areas of CYP450 induction, drug metabolism and pharmacogenetics. | 